4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-005574
EVP, CHIEF FINANCIAL OFFICER sold 773 shares at $19.96 ($15,429)
- EVP, CHIEF FINANCIAL OFFICER acquired 1,353 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-02-23 | Option exercise | +1,353 | 54,655 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-02-24 | Sale | −773 | $19.96 | $15,429 | 53,882 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-02-23 | Option exercise · Restricted Stock Units | −1,353 | 0 | D | ||
| Open-market sales · 773 sh · avg $19.96 · $15,429 | |||||||
Loading xslF345X05/form4-02252025_110254.xml…